ArticleProceedings of the National Academy of Sciences of the United States of America2022
Ethical, legal, and social issues in the Earth BioGenome Project.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Article
- Article
- Article
- Article
- Democratizing CRISPR? Legal complexity, access and the right to science.Nature biotechnology · 2026Article
- A Latitudinal Gradient of Reference Genomes.Molecular ecology · 2025Article
- A Latitudinal Gradient of Reference Genomes.Molecular ecology · 2025Article
- The Ecological Genome Project and the Promises of Ecogenomics for Society: Realising a Shared Vision as One Health.Bioethics · 2025Article
- The Earth BioGenome Project Phase II: illuminating the eukaryotic tree of life.Frontiers in science · 2025Article
- From ice cores to dinosaurs: physical collections managers' research data curation perceptions and behaviors.PloS one · 2025Article
- A new species ofIMA fungus · 2025Article
- Environmental DNA without borders : Let's embrace decentralised genomics to meet the UN's biodiversity targets.EMBO reports · 2024Article
- Article
- Indigenous peoples and local communities as partners in the sequencing of global eukaryotic biodiversity.npj biodiversity · 2023Review
- Indigenous peoples and local communities as partners in the sequencing of global eukaryotic biodiversity.npj biodiversity · 2023Review
- Indigenous peoples and local communities as partners in the sequencing of global eukaryotic biodiversity.npj biodiversity · 2023Review
- Global Action on Biodiversity May Hinge on Genetic Data Sharing Agreement.Advanced genetics (Hoboken, N.J.) · 2022Article
- Standards recommendations for the Earth BioGenome Project.Proceedings of the National Academy of Sciences of the United States of America · 2022Article
- Darwinian genomics and diversity in the tree of life.Proceedings of the National Academy of Sciences of the United States of America · 2022Article
- The Earth BioGenome Project 2020: Starting the clock.Proceedings of the National Academy of Sciences of the United States of America · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
The Earth BioGenome Project (EBP) is an audacious endeavor to obtain whole-genome sequences of representatives from all eukaryotic species on Earth. In addition to the project's technical and organizational challenges, it also faces complicated ethical, legal, and social issues. This paper, from members of the EBP's Ethical, Legal, and Social Issues (ELSI) Committee, catalogs these ELSI concerns arising from EBP. These include legal issues, such as sample collection and permitting; the applicability of international treaties, such as the Convention on Biological Diversity and the Nagoya Protocol; intellectual property; sample accessioning; and biosecurity and ethical issues, such as sampling from the territories of Indigenous peoples and local communities, the protection of endangered species, and cross-border collections, among several others. We also comment on the intersection of digital sequence information and data rights. More broadly, this list of ethical, legal, and social issues for large-scale genomic sequencing projects may be useful in the consideration of ethical frameworks for future projects. While we do not-and cannot-provide simple, overarching solutions for all the issues raised here, we conclude our perspective by beginning to chart a path forward for EBP's work.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.